Home
About
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Science
Our Approach
The B Cell Advantage
Research
Pipeline
Investors & Media
Press Releases
News Articles
Publications & Presentations
Contact
Careers
Home
About
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Science
Our Approach
The B Cell Advantage
Research
Pipeline
Investors & Media
Press Releases
News Articles
Publications & Presentations
Contact
Careers
News
All
Press Releases
News Articles
News Articles
October 13, 2021
Takeda to Work With Immusoft in $900 Million Rare-Disease Deal
Related
Press Releases
PR Newswire | January 27, 2025
Immusoft to Present Positive Data from the First Engineered B Cell in a Human Clinical Trial at the 21st Annual WorldSymposium™ 2025
Read More
Publications & Presentations
Global Genes | January 22, 2025
RARECast: Engineering B cells to Produce Therapeutic Proteins
Read More
